DALE VINCENT: Open Payments
NPI 1205164936 · BARDSTOWN, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,343 in 148 payments from 44 companies in 2025. Trend: 2023 $1,869 · 2024 $2,561 · 2025 $3,343
Food & beverage: $3,201Education: $143
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $275 |
| AstraZeneca Pharmaceuticals LP | 9 | $262 |
| Novartis Pharmaceuticals Corporation | 11 | $237 |
| Celgene Corporation | 8 | $182 |
| E.R. Squibb & Sons, L.L.C. | 10 | $171 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $145 |
| Daiichi Sankyo Inc. | 7 | $136 |
| Genentech USA, Inc. | 6 | $134 |
| PFIZER INC. | 7 | $124 |
| Gilead Sciences, Inc. | 6 | $124 |
Products named: VENCLEXTA, OPDIVO, REBLOZYL, ENHERTU, EPKINLY, Trodelvy, KISQALI, TAGRISSO.
Industry payments across KY — which companies pay providers there.
